Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Chiu

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Haematologica|September 22, 2018
Daratumumab plus bortezomib and dexamethasone <i>versus</i> bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTORAndrew Spencer, Suzanne Lentzsch, Katja Weisel, et al.
Biologicals : Journal of the International Association of Biological Standardization|January 17, 2025
Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies - A stakeholder meeting reportIrina Meln, Victor Cnossen, Nicoletta Corti, et al.
Nature|June 19, 2024
Human SARS-CoV-2 challenge uncovers local and systemic response dynamicsRik G H Lindeboom, Kaylee B Worlock, Lisa M Dratva, et al.
Nature|August 1, 2024
Author Correction: Human SARS-CoV-2 challenge uncovers local and systemic response dynamicsRik G H Lindeboom, Kaylee B Worlock, Lisa M Dratva, et al.
Lancet (London, England)|June 8, 2019
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 studyPhilippe Moreau, Michel Attal, Cyrille Hulin, et al.
Nature Immunology|April 8, 2024
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of diseaseFelicity Liew, Claudia Efstathiou, Sara Fontanella, et al.
Nature Communications|May 6, 2026
Predicting trajectories of illness using RNA velocity of whole bloodClaire Dunican, Clare Wilson, Dominic Habgood-Coote, et al.
Cell|August 13, 2024
High expression of oleoyl-ACP hydrolase underpins life-threatening respiratory viral diseasesXiaoxiao Jia, Jeremy Chase Crawford, Deborah Gebregzabher, et al.
The Journal of Experimental Medicine|November 22, 2024
Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C)Evangelos Bellos, Dilys Santillo, Pierre Vantourout, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Haematologica|September 22, 2018
Daratumumab plus bortezomib and dexamethasone <i>versus</i> bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTORAndrew Spencer, Suzanne Lentzsch, Katja Weisel, et al.
Biologicals : Journal of the International Association of Biological Standardization|January 17, 2025
Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies - A stakeholder meeting reportIrina Meln, Victor Cnossen, Nicoletta Corti, et al.
Nature|June 19, 2024
Human SARS-CoV-2 challenge uncovers local and systemic response dynamicsRik G H Lindeboom, Kaylee B Worlock, Lisa M Dratva, et al.
Nature|August 1, 2024
Author Correction: Human SARS-CoV-2 challenge uncovers local and systemic response dynamicsRik G H Lindeboom, Kaylee B Worlock, Lisa M Dratva, et al.
Lancet (London, England)|June 8, 2019
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 studyPhilippe Moreau, Michel Attal, Cyrille Hulin, et al.
Nature Immunology|April 8, 2024
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of diseaseFelicity Liew, Claudia Efstathiou, Sara Fontanella, et al.
Nature Communications|May 6, 2026
Predicting trajectories of illness using RNA velocity of whole bloodClaire Dunican, Clare Wilson, Dominic Habgood-Coote, et al.
Cell|August 13, 2024
High expression of oleoyl-ACP hydrolase underpins life-threatening respiratory viral diseasesXiaoxiao Jia, Jeremy Chase Crawford, Deborah Gebregzabher, et al.
The Journal of Experimental Medicine|November 22, 2024
Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C)Evangelos Bellos, Dilys Santillo, Pierre Vantourout, et al.
Pageof 13